Caution should be used if your child:
Intuniv is a non-stimulant treatment forattention-deficit/hyperactivity disorder (ADHD).
It is a long-acting form of guanfacine, which had previously been used to treat high blood pressure.
It may also be used alone (monotherapy) to treat ADHD.
Hinterhaus Productions / Getty Images
Weight-based target doses range from 0.05 to 0.12 milligram/kilogram/day.
This is a benefit for some children as it helps them fall asleep if given their dose at bedtime.
(Intuniv can either be given in the morning or the evening.)
Should Your Child With ADHD Try Intuniv?
Department of Health and Human Services.Pediatric postmarketing pharmacovigilance and drug utilization review.
Food and Drug Administration.Highlights of prescribing information: Intuniv (guanfacine) extended-release tablets, for oral use.
Revised August 15, 2018.
Food and Drug Administration.Pediatric focused safety review Intuniv (guanfacine ER) pediatric advisory committee meeting.
Published September 20, 2018.
Cincinnati Childrens.Tics, Tourette syndrome and medications.
Childress AC.Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.Adv Therapy.
Food and Drug Administration.Intuniv highlights of prescribing information.
2018;27(10):1283-1294. doi:10.1007/s00787-018-1113-4
